Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/120326
Title: | Adipocyte fatty-acid binding protein is overexpressed in cirrhosis and correlates with clinical outcomes |
Author: | Graupera, Isabel Coll, Mar Pose, Elisa Elia, Chiara Piano, Salvatore Solà, Elsa Blaya, Delia Huelin, Patricia Solé Padullés, Cristina Moreira, Rebeca de la Prada, Gloria Fabrellas i Padrès, Núria Juanola, Adrià Morales Ruiz, Manuel Sancho Bru, Pau Villanueva Sánchez, Càndid Ginès i Gibert, Pere |
Keywords: | Malalties del fetge Cirrosi hepàtica Àcids grassos Liver diseases Hepatic cirrhosis Fatty acids |
Issue Date: | 12-May-2017 |
Publisher: | Nature Publishing Group |
Abstract: | Fatty-acid-binding proteins (FABPs) are small intracellular proteins that coordinate lipid-mediated processes by targeting metabolic and immune response pathways. The aim of the study was to investigate plasma FABPs levels and their relationship with clinical outcomes in cirrhosis. Plasma levels of L-FABP1(liver and kidney), I-FABP2(intestine), and A-FABP4(adipocyte and macrophages) were measured in 274 patients with decompensated cirrhosis. Hepatic gene expression of FABPs was assessed in liver biopsies from patients with decompensated cirrhosis and in liver cell types from mice with cirrhosis. Immunohistochemistry of A-FABP4 in human liver biopsy was also performed. Plasma levels of FABPs were increased in patients with decompensated cirrhosis compared to those of healthy subjects (L-FABP1: 25 (17-39) vs 10 (9-17) ng/mL p = 0.001, I-FABP2: 1.1 (0.5-2.1) vs 0.6 (0.4-1) ng/ mL p = 0.04 and A-FABP4: 37 (20-68) vs 16 (11-33) ng/mL p = 0.002), respectively. Increased A-FABP4 levels were associated with complications of cirrhosis, acute-on-chronic liver failure and poor survival. Hepatic A-FABP4 gene expression was upregulated in decompensated cirrhosis. Macrophages were the main liver cell that over-expressed A-FABP4 in experimental cirrhosis and increased A-FABP4 was found in macrophages of human biopsies by immunohistochemistry. A-FABP4 levels are increased in decompensated cirrhosis and correlate with poor outcomes. Liver macrophages appear to be the main source of A-FABP4 in decompensated cirrhosis. |
Note: | Reproducció del document publicat a: https://doi.org/10.1038/s41598-017-01709-0 |
It is part of: | Scientific Reports, 2017, vol. 7, num. 1, p. 1829 |
URI: | http://hdl.handle.net/2445/120326 |
Related resource: | https://doi.org/10.1038/s41598-017-01709-0 |
ISSN: | 2045-2322 |
Appears in Collections: | Articles publicats en revistes (Infermeria de Salut Pública, Salut mental i Maternoinfantil) Articles publicats en revistes (Medicina) Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
671572.pdf | 1.42 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License